Science
Mechanism of Action
Topically, acetaminophen is thought to reduce itch by inhibiting prostaglandins that contribute to pruritic sensations. Its metabolites may also interact with and sensitize transient receptor potential vanilloid 1 (TRPV1) receptors, which are known mediators in both itch transmission and inflammatory processes within the skin.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 In double-blind, vehicle-controlled pilot studies involving healthy volunteers, topical acetaminophen gels at concentrations of 2.5% and 5% significantly reduced the intensity and duration of both histamine and cowhage-induced itch. These formulations demonstrated rapid skin penetration, with no observed adverse effects or alterations to heat pain thresholds.
- 02 A 1% topical acetaminophen concentration did not yield a statistically significant reduction in itch intensity when compared to a vehicle gel.
Transparency
Dusting Analysis
Acetaminophen is primarily an active pharmaceutical ingredient used internally for pain and fever, and it is not commonly found in cosmetic skincare products. If included in a cosmetic, its concentration would need to be within the 2.5-5% range to demonstrate the antipruritic efficacy observed in experimental studies. Use at sub-efficacious concentrations would constitute 'dusting' for marketing purposes, while use at effective concentrations for therapeutic claims would classify the product as an over-the-counter drug.
The Formula
Formulation
Stability
Acetaminophen's solubility in water is slight at cold temperatures but significantly increases with heat. It is freely soluble in alcohol and various organic solvents. Optimal stability for aqueous solutions is maintained within a pH range of 5.5-6.5, though it can undergo decomposition when exposed to strong alkalies.
Conflicts
- strong alkalies
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) has not specifically evaluated acetaminophen for its use as a cosmetic ingredient. The FDA has issued warnings regarding rare but serious and potentially fatal skin reactions, including Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), and acute generalized exanthematous pustulosis (AGEP), associated with acetaminophen use (primarily systemic). Individuals who have experienced such reactions are advised to avoid future use. In 2024, the FDA proposed mandating warnings about these severe skin reactions on over-the-counter acetaminophen product labels.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While experimental studies demonstrate promising antipruritic efficacy for topical acetaminophen at concentrations of 2.5-5%, the absence of a dedicated cosmetic safety review and the FDA's warnings regarding severe, rare skin reactions associated with its general use make its inclusion in precision skincare formulations highly questionable.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources
- nih.gov ↗
- medicaljournalssweden.se ↗
- clinicaltrials.gov ↗
- google.com ↗
- researchgate.net ↗
- patsnap.com ↗
- cir-safety.org ↗
- fda.gov ↗
- tylenol.com ↗
- rxlist.com ↗
- youtube.com ↗
- uspharmacist.com ↗
- acs.org ↗
- quora.com ↗
- termedia.pl ↗
- incidecoder.com ↗
- drugs.com ↗
- bemedwise.org ↗
- liverfoundation.org ↗
- healthgrades.com ↗